Determination of plasma homocysteine: Recommendations for test requesting;Determinazione dell'omocisteina plasmatica: Indicazioni per la richiesta

Biochimica Clinica

Volumn 38, Issue 3, 2014, Pages 234-237

  Szõke, Dominika ^a   Dolci, Alberto ^a   Russo, Umberto ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; VITAMIN B COMPLEX;

AMINO ACID BLOOD LEVEL; ARTERIAL THROMBOEMBOLISM; HOMOCYSTEINE BLOOD LEVEL; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; MEDICAL HISTORY; META ANALYSIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM;

EID: 84904704945     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Ntaios G, Savopoulos C, Chatzopoulos S, et al. Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis. Atherosclerosis 2011;214:11-9.
2. Pezzati P, Balboni F, Graziani MS. Iperomocisteinemia e rischio cardiovascolare: stato dell'arte. Biochim Clin 2010;34:173-85.
3. Carson NA, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962;37:505-13.
4. Humphrey LL, Fu R, Rogers K, et al. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008;83:1203-12.
5. NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009;55:378-84.
6. U.S. Preventive Services Task Force. Using non traditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:474-82.
7. Martí-Carvajal AJ, Solà I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2013;1:CD006612.
8. Huang T, Chen Y, Yang B, et al. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr 2012;31:448-54.
9. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37485 individuals. Arch Intern Med 2010;170:1622-31.
10. Jardine MJ, Kang A, Zoungas S, et al. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. Br Med J 2012;344:e3533.
11. Magner M, Krupkova L, Honzik T, et al. Vascular presentation of cystathionine beta-synthase deficiency in adulthood. J Inherit Metab Dis 2011;34:33-7.
12. Skovby F, Gaustadnes M, Mudd SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab 2010;99:1-3.
13. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72:185-92.
14. La Regina M, Orlandini F, Prisco D, et al. Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2010;30:2067-74.
15. Oussalah A, Guéant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 2011;34:1173-84.
16. Yang J, Hu X, Zhang Q, et al. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone 2012;51:376-82.
17. Zhu Y, He ZY, Liu HN. Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis. J Clin Neurosci 2011;18:933-8.
18. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012;29:133-49.
19. Hogeveen M, Blom HJ, den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis. Am J Clin Nutr 2012;95:130-6.
20. Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006;296:2720-6. (Pubitemid 44917549)
21. den Heijer M, Willems HP, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood 2007;109:139-44. (Pubitemid 46053054)
22. Homocysteine studies collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22.
23. Yap S, Boers GH, Wilcken B, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol 2001;21:2080-5. (Pubitemid 34219765)